These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 11011802

  • 21. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE.
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [Abstract] [Full Text] [Related]

  • 22. Low-molecular-weight heparins in thrombosis and cancer: emerging links.
    Mousa SA.
    Cardiovasc Drug Rev; 2004; 22(2):121-34. PubMed ID: 15179449
    [Abstract] [Full Text] [Related]

  • 23. Low molecular weight heparins and their clinical applications.
    Hao C, Sun M, Wang H, Zhang L, Wang W.
    Prog Mol Biol Transl Sci; 2019; 163():21-39. PubMed ID: 31030749
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention.
    Wong GC, Giugliano RP, Antman EM.
    JAMA; 2003 Jan 15; 289(3):331-42. PubMed ID: 12525234
    [Abstract] [Full Text] [Related]

  • 26. Preclinical studies on a low molecular weight heparin.
    Fareed J, Jeske W, Eschenfelder V, Iqbal O, Hoppensteadt D, Ahsan A.
    Thromb Res; 1996 Jan 15; 81(2 Suppl):S1-27. PubMed ID: 8822124
    [Abstract] [Full Text] [Related]

  • 27. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
    Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, Kluger J, Makanji S, Ashaye A, White CM.
    Pharmacotherapy; 2012 Sep 15; 32(9):799-808. PubMed ID: 22744711
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Low-molecular-weight heparins in the treatment of deep-vein thrombosis.
    Martineau P, Tawil N.
    Ann Pharmacother; 1998 May 15; 32(5):588-98, 601. PubMed ID: 9606481
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
    Ellison J, Thomson AJ, Conkie JA, McCall F, Walker D, Greer A.
    Thromb Haemost; 2001 Dec 15; 86(6):1374-8. PubMed ID: 11776302
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
    Maddineni J, Walenga JM, Jeske WP, Hoppensteadt DA, Fareed J, Wahi R, Bick RL.
    Clin Appl Thromb Hemost; 2006 Jul 15; 12(3):267-76. PubMed ID: 16959680
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. New antithrombotic agents for the prevention and treatment of deep vein thrombosis.
    Boneu B.
    Haemostasis; 1996 Oct 15; 26 Suppl 4():368-78. PubMed ID: 8979141
    [Abstract] [Full Text] [Related]

  • 38. Emerging anticoagulant and thrombolytic drugs.
    Iqbal O, Aziz S, Hoppensteadt DA, Ahmad S, Walenga JM, Bakhos M, Fareed J.
    Expert Opin Emerg Drugs; 2001 Apr 15; 6(1):111-35. PubMed ID: 15989500
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Current trends in antithrombotic drug and device development.
    Fareed J.
    Semin Thromb Hemost; 1996 Apr 15; 22 Suppl 1():3-8. PubMed ID: 8807721
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.